I agree that this site is using cookies. You can find further informations here.
X
Turlure, P.
55  results:
Search for persons X
?
1

P2-15 - Cohorte NaViRe: Observatoire en vie réelle des stra..:

Alain, S. ; Garnier-Geoffroy, F. ; Labrunie, A..
Journal of Epidemiology and Population Health.  72 (2024)  - p. 202669 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Évaluation des mesures de prévention des nausées-vomissemen..:

Benhamou, E. ; Jost, J. ; Turlure, P....
Le Pharmacien Clinicien.  59 (2024)  2 - p. e62-e63 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Effect of single-unit transfusion in patients treated for h..:

Chantepie, S.P. ; Mear, J.B. ; Briant, A.R....
Leukemia Research.  129 (2023)  - p. 107058 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Allogeneic transplantation in T‐cell lymphoma: Lessons from..:

Tournilhac, O. ; Altmann, B. ; Friedrichs, B....
Hematological Oncology.  41 (2023)  S2 - p. 512-513 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III:

Peterlin, P. ; Turlure, P. ; Chevallier, P....
Leukemia Research.  108 (2021)  - p. 106681.51 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Metabolic syndrome and cardiovascular disease after haemato..:

Greenfield, D. M. ; Salooja, N. ; Peczynski, C....
Bone Marrow Transplantation.  56 (2021)  11 - p. 2820-2825 , 2021
Link: https://doi.org/10.1038/..
 
?
7

Déficit musculaire à distance d'une allogreffe de moelle os..:

Auboiroux, M.M. ; Turlure, P. ; Vidal, N....
La Revue de Médecine Interne.  40 (2019)  - p. A149-A150 , 2019
Link: https://doi.org/10.1016/..
 
?
8

EBMT prospective observational study on allogeneic hematopo..:

Wiktor-Jedrzejczak, W. ; Drozd-Sokolowska, J. ; Eikema, D. J....
Bone Marrow Transplantation.  54 (2019)  9 - p. 1391-1398 , 2019
Link: https://doi.org/10.1038/..
 
?
9

Stable Disease with Hematologic Improvement is Clinically M..:

Schuh, A.C. ; Döhner, H. ; Seymour, J.F....
Leukemia Research.  55 (2017)  - p. S68-S69 , 2017
Link: https://doi.org/10.1016/..
 
?
10

REDUCED INTENSITY (FB2) VS REDUCED TOXICITY MYELOABLATIVE (..:

Le Bourgeois, A. ; Labopin, M. ; Blaise, D....
Hematological Oncology.  35 (2017)  S2 - p. 193-194 , 2017
Link: https://doi.org/10.1002/..
 
?
11

A Time-Dependent Model Describes Methotrexate Elimination a..:

Woillard, J.-B. ; Debord, J. ; Saint-Marcoux, F....
Clinical Therapeutics.  39 (2017)  8 - p. e28 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Reduced-intensity and non-myeloablative allogeneic stem cel..:

Gauthier, J ; Castagna, L ; Garnier, F...
Bone Marrow Transplantation.  52 (2017)  5 - p. 689-696 , 2017
Link: https://doi.org/10.1038/..
 
?
13

Autologous stem cell transplantation for patients aged 60 y..:

Stamatoullas, A ; Brice, P ; Gueye, M S...
Bone Marrow Transplantation.  51 (2016)  7 - p. 928-932 , 2016
Link: https://doi.org/10.1038/..
 
?
14

Acute lymphoblastic leukemia relapsing after first-line ped..:

Desjonquères, A ; Chevallier, P ; Thomas, X...
Blood Cancer Journal.  6 (2016)  12 - p. e504-e504 , 2016
Link: https://doi.org/10.1038/..
 
?
15

Greffes de cellules souches hématopoïétiques à partir d'un ..:

Nguyen, S. ; Blaise, D. ; Bay, J.-O....
Pathologie Biologie.  62 (2014)  4 - p. 185-189 , 2014
Link: https://doi.org/10.1016/..
 
1-15